A Phase III, Randomized, Controlled Trial of the Fully Human IL-12/23 mAb Briakinumab in Moderate-to-Severe Psoriasis
Titel:
A Phase III, Randomized, Controlled Trial of the Fully Human IL-12/23 mAb Briakinumab in Moderate-to-Severe Psoriasis
Auteur:
Gordon, Kenneth B. Langley, Richard G. Gottlieb, Alice B. Papp, Kim A. Krueger, Gerald G. Strober, Bruce E. Williams, David A. Gu, Yihua Valdes, Joaquin M.